Bioceres Crop Solutions Q4 Fiscal 2026 Earnings: Revenue Holds at $55.9 Million as Adjusted EBITDA Turns Positive

Bioceres (BIOX) reported a challenging fiscal year 2026 with an 18% revenue decline to $238M, driven by seed business reconfiguration and lower crop protection performance. Quarterly revenue was $55.9M, with crop nutrition revenue growing 36%. Adjusted EBITDA improved to $600K from a $9.6M loss, aided by a 19% reduction in SG&A expenses. The company faces litigation and debt restructuring challenges, with total financial debt at $225.9M. Management targets a 40% gross margin for fiscal 2027 and

American Eagle Outfitters (AEO) reported Q2 FY26 revenue of $1.38B, up 8% YoY, with EPS of $0.79. Aerie's sales grew 19%, while American Eagle's fell 1%. Tariff refunds added $161M to operating income. AEO expects FY26 operating income of $540M-$550M, including refunds. Hedge fund ownership declined, with BlackRock as the largest stakeholder.

United Natural Foods (UNFI) reported Q4 FY26 adjusted EBITDA of $172M, up 48.3% YoY, and adjusted EPS of $0.69, reversing a prior-year loss. Full-year adjusted EBITDA grew 27% to $701M. Net sales declined 0.7% YoY due to optimization initiatives. Capital spending rose to $117M, reducing free cash flow. Hedge fund ownership declined, with BlackRock as the largest stakeholder. FY27 guidance expects modest sales growth and margin expansion.

Bank of America analyst Sara Senatore raised her price target for Jersey Mike's Subs (JMKE) to $29, citing improving traffic trends and digital sales growth. The company reported Q2 same-store sales growth of 2.3% and systemwide sales of $1.21 billion. Despite near-term expense pressures, BofA maintains a Buy rating, expecting long-term growth. JMKE opened 83 new restaurants in Q2, with a target of over 7,500 domestic stores by 2036.

Kestra Medical Technologies (KMTS) reported Q1 FY2027 revenue of $31.0M, beating estimates and raising FY2027 guidance to $141M. Gross margin improved to 56.5%, but EPS missed by 66.7%. Management expects mid-70% gross margin in 2–3 years. Next catalysts include late-stage R&D updates and Q2 earnings. Analysts maintain a Strong Buy rating with $30 price targets.

Dave & Buster's (PLAY) Q2 revenue fell to $544.1M from $557.4M, with a net loss of $12.5M. Same-store sales declined 2.9%, but improved from Q1. Adjusted EBITDA dropped to $98.9M. CEO Harper noted improved sales trends and plans for price increases. CFO Hatton expects $15M in savings over the next year.